June 6, 2002
Boehringer Ingelheim Pharmaceuticals, Inc. Has
Recalled Combivent Inhalation Aerosol
Ridgefield, CT (SafetyAlerts)
- The Food and Drug Administration (FDA) said Boehringer Ingelheim
Pharmaceuticals, Inc. has recalled Combivent Inhalation Aerosol.
Combivent Inhalation Aerosol (ipratropium bromide 18 mcg and albuterol
sulfate 103 mcg) 14.7g canister, 200 metered actuations, Rx only. Recall
165090A, Exp. Date May-03
165092A, Exp. Date May-03.
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, by FED EX on May
21, 2002. Firm initiated recall is ongoing.
Defective container; inhaler may not fire properly and patients will not
receive their full dose of medication.
VOLUME OF PRODUCT IN COMMERCE
192,089 units total.